Cointime

Algonomics

company

About

Algonomics provides structural bioinformatics services to develop rationally designed therapeutics in the field of immunotherapy.

  • 10001 - max

Highlights

Total Funding Amount
€1.50M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€1.50M
Industries
Bioinformatics,Biotechnology,Therapeutics
Founded date
Jan 1, 1999
Number Of Employee
10001 - max
Operating Status
Active

AlgoNomics is a Belgium based biotech company providing structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains innovative tools to unravel protein-protein and protein-peptide interactions. AlgoNomics' premier product is the Epibase® platform for T-cell epitope identification in different population groups, applied in the discovery of vaccines and therapeutic proteins.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€1.50M
Algonomics has raised a total of €1.50M in funding over 2 rounds. Their latest funding was raised on Jun 20, 2007 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 20, 2007 Series Unknown €1.50M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Algonomics is funded by 2 investors. Baekeland Funds and TrustCapital are the most recent investors.
Investor Name Lead Investor Funding Round
Baekeland Funds — Series Unknown
TrustCapital — Series Unknown
Cointime
เนื้อหา
บริษัท